new DelhiOne hour ago
- copy link
The Government of India has approved the world’s first nasal corona vaccine. Hyderabad-based Bharat Biotech, which manufactures Covaxin, has developed it in collaboration with the Washington University School of Medicine (WUSM). This vaccine taken from the nose can be applied as a booster dose. Firstly it will be made available in private hospitals, for which people will have to pay. According to the news agency, it has been included in the Corona vaccination program from today itself.
This nasal vaccine of Bharat Biotech has been named iNCOVACC. Earlier it was named BBV154. It will be delivered to the body through the nose. Its special thing is that it blocks both infection and transmission of corona as soon as it enters the body. This vaccine does not require injection, so there is no risk of injury. Also, healthcare workers will not need special training.
What is nasal vaccine?
At present, we are being vaccinated through injection into the muscles. This vaccine is called intramuscular vaccine. A nasal vaccine is one that is given through the nose. Because it is given through the nose, it is called an intranasal vaccine. That is, it does not need to be given by injection, nor is it administered like an oral vaccine. It’s kind of like a nasal spray.
How does the nasal vaccine work?
Many microbes, including the coronavirus, enter the body through mucosa (the moist, sticky substance that lines the nose, mouth, lungs, and digestive tract). The nasal vaccine produces an immune response directly in the mucosa itself.
That is, the nasal vaccine raises soldiers to fight from where the virus infiltrates the body. The nasal vaccine causes your body to produce immunoglobulin A (igA). IgA is believed to be more effective in preventing infection in the early stages. It prevents infection as well as prevents transmission.
The nasal vaccine is delivered through a pump into the nose. Only a few drops of it are required to be given in a dose.
How different is it from other vaccines?
So far 8 vaccines have been approved in the country. These are all intramuscular vaccines, that is, they are given through injection. Whereas, BBV154 is an intranasal vaccine. If it is approved, it will be the country’s first intranasal vaccine. Right now Sputnik, Covishield and Covaxin are being installed in the country. All these three vaccines are double dose vaccines. BBV154 will only be given once.
Only one dose of nasal vaccine is effective
- At present, two doses of the vaccine being used in India are being given. The vaccinated person is considered safe 14 days after the second dose. In such a situation, the nasal vaccine starts showing its effect within 14 days.
- Effective nasal dosage will not only protect against coronavirus, but will also prevent the spread of the disease. Even mild symptoms will not be seen in the patient. The virus will also not be able to harm other parts of the body.
- This is a single dose vaccine, due to which tracking is easy. Its side effects are also less as compared to intramuscular vaccine. Another big advantage of this is that there will be less waste of needles and syringes.
Vaccine will be given like booster dose
The intranasal vaccine will be given as a booster dose to those taking vaccines like Covaxin and Covishield. However, it can also be used as a primary vaccine. Bharat Biotech’s Managing Director and Chairman Dr. Krishna Ella had said some time ago that like polio, 4 drops of this vaccine is also enough. Two drops will be put in both the nostrils.
Do read this special news of Bhaskar related to the increasing danger of Corona in the country and the world.
The world is horrified to see the action of BF.7 variant in China: dodging the antibodies made from the vaccine
Hospitals are once again filling up in China. Medicines are running out. Mass funerals are being performed. The reason is the corona virus spreading like fire. Omicron’s variant BF.7 is responsible for such a fast spreading infection. WHO officials say that this is the fastest spreading variant ever. Read full news…
Corona threat in the world: 1 million cases daily in China, 20 days waiting in crematoriums
The situation is getting worse in China due to Corona. Airfinity, a London-based global health intelligence company, claims that one million corona patients are coming to the fore daily in China. Also, 5 thousand deaths are happening in 24 hours. If this continues, the daily cases will increase to 37 lakh in January. At the same time, in March this figure will be 42 lakhs. Read full news…
IMA said- Immunity of people in India is more strong, there will be no need for lockdown
Dr. Anil Goyal of the Indian Medical Association (IMA) said on Thursday that there would be no need for a lockdown in India. According to IMA, the immunity of the people of India is stronger than that of China. 95% of India’s population has immunity against Corona, so there will be no lockdown in the country. Read full news…